“Stephane was extremely helpful for us to see the potential in certain markets. He clearly knows his subject area and is thus able to ask the right questions, offer insightful commentary and provide analysis that makes him stand apart from others. I highly recommend Stephane and DeciBio.”
Los Angeles, California, United States
Contact Info
8K followers
500+ connections
Los Angeles, California, United States
Contact Info
8K followers
500+ connections
About
Stephane Budel is a founding Partner at DeciBio. He is an accomplished business manager…
Activity
-
I am very much looking forward to ADLM next week - do come and see me and my colleagues at the TTP plc stand - number 952. It will be good to see…
I am very much looking forward to ADLM next week - do come and see me and my colleagues at the TTP plc stand - number 952. It will be good to see…
Liked by Stephane Budel
-
Spotlight in HealthTech - Towards the Next Generation Throwback to this year's BioTrinity and joining Inga D. to share our perspectives on…
Spotlight in HealthTech - Towards the Next Generation Throwback to this year's BioTrinity and joining Inga D. to share our perspectives on…
Liked by Stephane Budel
Experience & Education
-
DeciBio
View Stephane’s full experience
See their title, tenure and more.
or
Volunteer Experience
-
Advisor
Larta Institute
- Present 14 years 6 months
Science and Technology
Invited advisor at the Larta Institute FeedForward™ Session events supported by the National Institutes of Health that gathers U.S. start-ups that have received non-dilutive funding from NIH to take their innovations to market ($90M+ in 2016). These start-ups have been competitively selected to participate in Larta’s national-scale NIH Commercialization Accelerator Program (NIH CAP), of which the FeedForward Sessions are a key program component.
FeedForward Sessions are invitation-only…Invited advisor at the Larta Institute FeedForward™ Session events supported by the National Institutes of Health that gathers U.S. start-ups that have received non-dilutive funding from NIH to take their innovations to market ($90M+ in 2016). These start-ups have been competitively selected to participate in Larta’s national-scale NIH Commercialization Accelerator Program (NIH CAP), of which the FeedForward Sessions are a key program component.
FeedForward Sessions are invitation-only workshops for life science/healthcare entrepreneurs to receive individualized and group input and in a candid and informal setting. Participants providing feedback include senior industry BD and external discovery leaders, investors, and stakeholders in the medical and healthcare community.
Patents
-
RNAi modulation of the Rho-A gene in research models
US 20070044161 A1
TECHNICAL FIELD
The invention relates to compositions and methods for modulating the expression of RhoA, and more particularly to the downregulation of RhoA mRNA and RhoA protein levels by oligonucleotides via RNA interference, e.g., chemically modified oligonucleotides.Other inventors -
Projects
Languages
-
French
Native or bilingual proficiency
-
English
Native or bilingual proficiency
Recommendations received
2 people have recommended Stephane
Join now to viewOther similar profiles
-
Andrew Aijian
Connect -
Colin Enderlein
Connect -
Megan Nacar
Connect -
Rishikesh Kayathi
Precision Medicine | Business | Data |
Connect -
Elle Nouveau
Connect -
Pranay Madan
Partner, DeciBio
Connect -
Maximilian Schmid, M.D.
Connect -
Michelle Atallah
Connect -
Brian Krueger, PhD
Connect -
Phillip Leclair
Senior Analyst at DeciBio Consulting
Connect
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More